SmithKline Files Suit Against Antacid Rival: The...
SmithKline Files Suit Against Antacid Rival: The battle between the world’s drug giants for America’s heartburn sufferers flared this week, with SmithKline Beecham announcing a suit against a rival that makes the Pepcid AC heartburn remedy. SmithKline Beecham alleges that the Johnson & Johnson/Merck & Co. joint venture used “blatantly false claims” in commercials for over-the-counter Pepcid. SmithKline makes a rival medicine, Tagamet HB, which it launched earlier this month. Merck and Johnson & Johnson defended the Pepcid AC ads. “We have solid support for our claims and are confident they will be substantiated in court,” a Merck spokesman said.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
